2024
|
Invention
|
Molecular switch-mediated control of engineered cells.
The present disclosure relates to therape... |
2023
|
Invention
|
System and method for a flexible pressure sensor for gastrointestinal manometry.
A system for as... |
2021
|
Invention
|
Agents for reversing toxic proteinopathies. The present disclosure relates to compositions and me... |
2020
|
Invention
|
Compositions, methods and uses for free fatty acid screening of cells at scale.
The present disc... |
|
Invention
|
Compositions, methods and uses for free fatty acid screening of cells at scale. The present discl... |
2019
|
Invention
|
N-3 immunoresolvents: structures and actions. The invention describes novel mono-hydroxy, di-hydr... |
|
Invention
|
Compounds that enhance atoh1 expression. This invention generally provides compounds, pharmaceuti... |
|
Invention
|
Genetically encoded biosensors.
The present disclosure provides, inter alia, genetically encoded... |
2018
|
Invention
|
Papd5 inhibitors and methods of use thereof. The disclosure relates to compounds that are, e.g., ... |
|
Invention
|
Flexible piezoelectric devices for gastrointestinal motility sensing. Improvements in ingestible ... |
|
Invention
|
Genetically encoded biosensors. The present disclosure provides, inter alia, genetically encoded ... |
|
Invention
|
Compositions and methods for treating tuberous sclerosis complex.
Provided herein are methods of... |
|
Invention
|
Compositions and methods for treating tuberous sclerosis complex. Provided herein are methods of ... |
|
Invention
|
Methods for detecting ovarian cancer using extracellular vesicles for molecular analysis. The pre... |
2017
|
Invention
|
Il1rl-1 as a cardiovascular disease marker and therapeutic target. This invention pertains to met... |
2016
|
Invention
|
Tissue extraction devices and related methods. In accordance with an aspect of the present disclo... |
2015
|
Invention
|
Compounds for use in screening methods for spinal muscular atrophy.
Disclosed herein are composi... |
|
Invention
|
Disease-associated genetic variations and methods for obtaining and using same.
The invention pr... |
|
Invention
|
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin. Describe... |
2014
|
Invention
|
14-hydroxy-docosahexaenoic acid compounds. The invention describes novel 14-hydroxy docosahexaeno... |
|
Invention
|
Compositions and methods for selecting a treatment for b-cell neoplasias.
The present invention ... |
|
Invention
|
Systems and method for high-throughput testing. The systems and methods described herein relate t... |
|
Invention
|
Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions. T... |
|
Invention
|
1l1rl-1 as a cardiovascular disease marker and therapeutic target. This invention pertains to met... |
|
Invention
|
Novel n-3 immunoresolvents: structures and actions. The invention describes novel mono-hydroxy, d... |
2013
|
Invention
|
Methods and reagents for detection and treatment of esophageal metaplasia.
The invention describ... |
2012
|
Invention
|
Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents.
Disclo... |
2010
|
Invention
|
Biomarkers to identify hiv-specific t-cell subsets. The invention relates to expression profiles ... |
|
Invention
|
Disrupting fcrn-albumin interactions. Provided herein are, inter alia, methods for identifying a ... |
|
Invention
|
Application of polymeric materials to screens to facilitate hemostasis and wound healing. This in... |
|
Invention
|
Methods of treating colitis involving il-13 and nk-t cells. Method of treating or preventing the ... |
2009
|
Invention
|
Biomarkers for predicting prostate cancer progression. The present invention relates to the ident... |
2007
|
Invention
|
Method of cultivating cell or tissue. A method of cultivating a culture of cell, tissue, etc. The... |
|
Invention
|
Method for ablating with needle electrode. A method for ablating tissue in or around the heart to... |
|
Invention
|
Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthri... |
2006
|
Invention
|
Inhibition of tnf-alpha-initiated response.
The impact of lipoxin A4 (LXA4) and aspirin-triggere... |
|
Invention
|
Sterile access conduit.
An elongate flexible conduit including a sealing membrane is positioned ... |